US R&D Champions ETF

USRD

Expense Ratio

0.29%

NAV as of Jun 18, 2025

$30.81

+$0.01
+0.03%

Year-To-Date Change

3.56%

Overview

The Themes US R&D Champions ETF (USRD) seeks to track the Solactive US R&D Champions Index (SOLURDCT), which identifies 50 profitable R&D companies with:

  • 3 years of Increasing R&D Spending
  • 3 years of Positive Return on Equity (ROE)
  • Positive Profit Margins

USRD seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the SOLURDCT Index.

Potential Benefits of USRD

Fees Over % Lower than the Category Average*

*Source: etf.com,Universe of 167 Fundamental ETFs, as of May 9, 2025

Key facts

Key Information

ETF Name Themes US R&D Champions ETF
Active/Passive Management Passive index
Inception Date Dec 13, 2023
Total Expense Ratio 0.29%
NAV $30.81

Trading Details

Ticker USRD
Index Name Solactive US R&D Champions Index
Index Provider Solactive
Index Ticker SOLURDCT Index
CUSIP 882927874
ISIN US8829278741
Primary Exchange Nasdaq
Shares Outstanding 30,000
Number of holdings 51
30-Day Median Bid/Ask Spread 0.23%
Rebalance Frequency Quarterly

Distributions

As of 6/19/25
30-Day SEC Yield 0%
Distribution Frequency Annual

ETF Prices

As of 6/18/25
Price Daily Change Daily Change %
NAV $30.81 +$0.01 +0.03%
Market Price $30.80 -$0.00 -0.01%

Holdings & Characteristics

Top Holdings*

As of 06/19/25

Name Ticker Weight
Oracle Corp ORCL 2.72%
Super Micro Computer Inc SMCI 2.53%
Vertiv Holdings Co VRT 2.53%
Advanced Micro Devices Inc AMD 2.36%
Broadcom Inc AVGO 2.36%
Trade Desk Inc/The TTD 2.32%
Lam Research Corp LRCX 2.31%
Meta Platforms Inc META 2.26%
Estee Lauder Cos Inc/The EL 2.26%
Axon Enterprise Inc AXON 2.25%

*Holdings Subject to Change

SECTOR WEIGHT (%)
Information Technology
52.99%
Health Care
17.83%
Communication Services
8.42%
Industrials
6.81%
Consumer Cyclicals
5.84%
Consumer Non-Cyclicals
3.90%
Materials
2.17%
Real Estate
1.95%
Others
0.10%
SECTOR WEIGHT (%)
United States
99.90%
Others
0.10%

Performance

Performance History

Fund NAV Market Price Index
1 Month N/A N/A N/A
3 Months N/A N/A N/A
6 Months N/A N/A N/A
1 Year N/A N/A N/A
3 Years N/A N/A N/A
5 Years N/A N/A N/A
Since Inception 14.86% 14.84% 17.32%
YTD N/A N/A N/A
Fund NAV Market Price Index
1 Month 0.10% 0.10% 0.09%
3 Months 9.68% 9.69% 9.77%
6 Months 1.12% 0.95% 3.63%
1 Year 5.41% 5.48% 8.54%
3 Years N/A N/A N/A
5 Years N/A N/A N/A
Since Inception 23.24% 23.20% 27.24%
YTD 3.56% 3.60% 3.65%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (NBBO) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses, or sales charges. One

Documents

Join Our Newsletter

Sign up to receive timely updates on our Thematic and Single Stock ETFs, premium insights, and expert analysis.